Stability of clinical etiologic diagnosis in dementia and mild cognitive impairment: Results from a multicenter longitudinal database

American Journal of Alzheimer's Disease and other Dementias

Volumn 28, Issue 8, 2013, Pages 750-758

  Koepsell, Thomas D ^a   Gill, Dawn P ^a,b   Chen, Baojiang ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

dementia diagnosis; dementia etiology; diagnosis stability

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CHARLSON COMORBIDITY INDEX; CLINICAL DEMENTIA RATING; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DEMENTIA; DEPRESSION; DIFFUSE LEWY BODY DISEASE; DOWN SYNDROME; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; HUNTINGTON CHOREA; HYDROCEPHALUS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL INSTABILITY; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; PARKINSON DISEASE; PRIMARY PROGRESSIVE APHASIA; PRION; PROGRESSIVE SUPRANUCLEAR PALSY; RELIABILITY; RISK FACTOR; TRAUMATIC BRAIN INJURY; VERY ELDERLY;

DEMENTIA DIAGNOSIS; DEMENTIA ETIOLOGY; DIAGNOSIS STABILITY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APHASIA, PRIMARY PROGRESSIVE; DEMENTIA; DEMENTIA, VASCULAR; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMANS; LEWY BODY DISEASE; LONGITUDINAL STUDIES; MALE; MARKOV CHAINS; MILD COGNITIVE IMPAIRMENT; PARKINSON DISEASE;

EID: 84890938727     PISSN: 15333175     EISSN: 19382731     Source Type: Journal    
DOI: 10.1177/1533317513504611     Document Type: Article

References (21)

1. Kukull WA, Bowen JD. Dementia epidemiology. Med Clin North Am. 2002 ; 86 (3). 573-590
2. Lambracht-Washington D, Qu BX, Fu M, Eagar TN, Stuve O, Rosenberg RN. DNA beta-amyloid(1-42) trimer immunization for Alzheimer disease in a wild-type mouse model. JAMA. 2009 ; 302 (16). 1796-802
3. Gilman S, Koller M, Black RS, et al. Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology. 2005 ; 64 (9). 1553-1562
4. Windisch M, Wolf HJ, Hutter-Paier B, Wronski R. Is alpha-synuclein pathology a target for treatment of neurodegenerative disorders?. Curr Alzheimer Res. 2007 ; 4 (5). 556-561
5. Skovronsky DM, Lee VMY, Trojanowski JQ. Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu Rev Pathol. 2006 ; 1: 151-170
6. Zhou J, Yu Q, Zou T. Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies. BMC Neurosci. 2008 ; 9 (suppl 2). S10
7. Birks J, Flicker L. Investigational treatment for vascular cognitive impairment. Expert Opin Investig Drugs. 2007 ; 16 (5). 647-658
8. Chabriat H, Bousser MG. Vascular dementia: potential of antiplatelet agents in prevention. Eur Neurol. 2006 ; 55 (2). 61-69
9. Aisen PS, Andrieu S, Sampaio C, et al. Report of the task force on designing clinical trials in early (predementia) AD. Neurology. 2011 ; 76 (3). 280-286
10. Jack CR, Albert MS, Knopman DS, et al. Introduction to the recommendations from the National institute on aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011 ; 7 (3). 257-262
11. Morris JC, Weintraub S, Chui HC, et al. The uniform data set (UDS): clinical and cognitive variables and descriptive data from Alzheimer disease centers. Alzheimer Dis Assoc Disord. 2006 ; 20 (4). 210-216
12. Fleiss JL, Bruce L, Paik MC Statistical Methods for Rates and Proportions. 3 rd ed.New York, NY: Wiley and Sons; 2003. New York, NY: Wiley and Sons ; 2003:
13. Sato T, Matsuyama Y. Marginal structural models as a tool for standardization. Epidemiology. 2003 ; 14 (6). 690-686
14. Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000 ; 11 (5). 550-560
15. Efron B, Tibshirani RJ An Introduction to the Bootstrap. London: Chapman and Hall ; 1993:
16. Lindsey JK Statistical Analysis of Stochastic Processes in Time. New York, NY: Cambridge University Press ; 2004:
17. Jackson C Multi-state Modelling with R: the Msm Package. Vienna, Austria: R Project document ; 2009:
18. Malmstrom TK, Miller DK, Coats MA, Jackson P, Miller JP, Morris JC. Informant-based dementia screening in a population-based sample of African Americans. Alzheimer Dis Assoc Disord. 2009 ; 23 (2). 117-123
19. Carr DB, Gray S, Baty J, Morris JC. The value of informant versus individual's complaints of memory impairment in early dementia. Neurology. 2000 ; 55 (11). 1724-1726
20. Gabel MJ, Foster NL, Heidebrink JL, et al. Validation of consensus panel diagnosis in dementia. Arch Neurol. 2010 ; 67 (12). 1506-1512
21. Breteler MB. Mapping out biomarkers for Alzheimer disease. JAMA. 2011 ; 305 (3). 304-305